Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Advances in Experimental Medicine and Biology|August 16, 2011
Influenza vaccines: what do we want and how can we get it?Felix Geeraedts, Anke HuckriedeExpert Review of Vaccines|August 28, 2018
Effector mechanisms of influenza-specific antibodies: neutralization and beyondFederica Sicca, Sam Neppelenbroek, Anke HuckriedeMethods in Enzymology|January 13, 2004
Influenza virosomes in vaccine developmentAnke Huckriede, Laura Bungener, Toos Daemen, et al.Vaccine|February 12, 2020
Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreementFederica Sicca, Donata Martinuzzi, Emanuele Montomoli, et al.Bioscience Reports|November 14, 2002
Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMsLaura Bungener, Anke Huckriede, Jan Wilschut, et al.Journal of Liposome Research|April 25, 2007
Cellular delivery of siRNA mediated by fusion-active virosomesAnke Huckriede, Jørgen De Jonge, Marijke Holtrop, et al.Human Vaccines & Immunotherapeutics|September 18, 2015
Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic reviewEva van Doorn, Heng Liu, Anke Huckriede, et al.Autoimmunity Reviews|April 7, 2007
Influenza vaccination in systemic lupus erythematosus: safe and protective?Bert Holvast, Anke Huckriede, Cees G M Kallenberg, et al.ALTEX|January 15, 2021
In vitro assessment of tick-borne encephalitis vaccine: Suitable human cell platforms and potential biomarkersAurora Signorazzi, Marilena P Etna, Eliana M Coccia, et al.Vaccine|December 1, 2024
Assessing human B cell responses to influenza virus vaccines and adjuvants in a PBMC-derived in vitro culture systemShuran Gong, Martin Beukema, Jacqueline De Vries-Idema, et al.Pageof 8